Evidence map›Paper›PMID 38961521›Full record

ArticleNeuropsychopharmacology reports2024

Successful utilization of clozapine for a patient with treatment-resistant schizophrenia after recurrent violent behavior.

Rikuto Christopher Shinohara, Tomomi Oshima, Takafumi Otsubo, Keita Ariga, Tesshu Ono, Koya Muneoka, Hiroki Umezu, Nobuhiro Mikami

Abstract readCase Reports
In one paragraph

Article in Neuropsychopharmacology reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Rikuto Christopher ShinoharaDepartment of Psychiatry, Kushiro City General Hospital, Kushiro, Japan.ORCID 0009-0006-5169-0891
Tomomi OshimaDepartment of Psychiatry, Kushiro City General Hospital, Kushiro, Japan.
Takafumi OtsuboDepartment of Psychiatry, Kushiro City General Hospital, Kushiro, Japan.
Keita ArigaDepartment of Psychiatry, Kushiro City General Hospital, Kushiro, Japan.
Tesshu OnoDepartment of Psychiatry, Kushiro City General Hospital, Kushiro, Japan.
Koya MuneokaDepartment of Psychiatry, Kushiro City General Hospital, Kushiro, Japan.
Hiroki UmezuDepartment of Psychiatry, Kushiro City General Hospital, Kushiro, Japan.
Nobuhiro MikamiDepartment of Psychiatry, Kushiro City General Hospital, Kushiro, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn patients with schizophrenia, violent behavior is a clinically important factor that prevents their discharge. Clozapine is an effective antipsychotic medication for treatment-resistant schizophrenia, and its usefulness for aggressive behavior has also been suggested. CASE PRESENTATION: We present the case of a 38-year-old male patient diagnosed with schizophrenia who was successfully treated with clozapine after recurrent violent behavior. He was diagnosed with schizophrenia during his adolescence. He was hospitalized for treatment in his teens, but his hallucinations and delusions persisted even after discharge. In his 30s, he became noticeably emotionally unstable, and despite being treated for an adequate period with sufficient doses of several antipsychotics, his symptoms did not improve. This led to repeated hospitalizations triggered by violent behavior toward his parents and siblings within the home. During his fourth hospitalization, clozapine was initiated due to multiple incidents of violence toward nursing staff secondary to hallucinations and delusions. As the dose of clozapine was gradually increased with therapeutic drug monitoring, the patient's hostility, uncooperativeness, and suspiciousness markedly improved, and his aggressive behavior disappeared. He was discharged to a facility on day 194 after starting clozapine and has continued outpatient visits.

conclusionClozapine was suggested to be effective for aggressive behavior in patients with treatment-resistant schizophrenia and should be actively considered. In such cases, regular measurement of blood concentration is useful for adjusting the dosage of clozapine.

Indexed as

Antipsychotic AgentsClozapineSchizophrenia, Treatment-ResistantViolenceAdultAggressionHallucinationsHumansMaleRecurrenceSchizophreniaSchizophrenic PsychologyAntipsychotic AgentsClozapineclozapineschizophreniatreatment‐resistantviolence

Identifiers

PMID38961521
PMCPMC11544433

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.